Concepedia
Statistics
Publications
6
Citations
130
H-Index
Active since
2019
Affiliations
Shizuoka Cancer Center(Current)
Shimane University
Wakayama Medical University
Osaka International Cancer Institute
Juntendo University
Kazuhisa Nakashima is an author at Shizuoka Cancer Center specializing in oncology, egfr inhibition, and lung cancer pharmacotherapy.
Publications per year
2019–2024
A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
Daichi Fujimoto, Satoru Miura, Kenichi Yoshimura et al. · JTO Clinical and Research Reports · 2021 · 48 citations · Full text
Medicine, Oncology, Pharmacotherapy +7
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
Kazuhisa Nakashima, Yuichi Ozawa, Haruko Daga et al. · Investigational New Drugs · 2020 · 27 citations
Medicine, Oncology, Pharmacotherapy +15
Osimertinib for patients with EGFR T790M mutation-positive non–small-cell lung cancer and a poor performance status
Kazuhisa Nakashima, Madoka Kimura, Hiroaki Akamatsu et al. · Japanese Journal of Clinical Oncology · 2019 · 22 citations
Medicine, Oncology, Pharmacology +16
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
Naoya Nishioka, Hisao Imai, Masahiro Endo et al. · Targeted Oncology · 2024 · 13 citations · Full text
Medicine, Oncology, Pharmacology +13
High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma
T Hotta, Kazuhisa Nakashima, Kojiro Hata et al. · Journal of Thoracic Disease · 2021 · 10 citations · Full text
1–5 of 6